TT International Asset Management’s BioNTech BNTX Stock Holding History

TT International Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-8,000	Closed	-$996K	–	40
2023 Q1	$996K	Sell	8,000 -4,000	-33%	-$549K	0.11%	37
2022 Q4	$1.8M	Buy	12,000 +8,500	+243%	+$1.31M	0.18%	25
2022 Q3	$472K	Hold	3,500	–	–	0.05%	33
2022 Q2	$521K	Buy	+3,500	New	+$535K	0.05%	35
2021 Q3	–	Sell	-3,000	Closed	-$671K	–	69
2021 Q2	$671K	Sell	3,000 -5,000	-63%	-$943K	0.03%	67
2021 Q1	$652	Hold	8,000	–	–	0.03%	59
2020 Q4	$652K	Buy	+8,000	New	+$785K	0.03%	55

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TT International Asset Management's BNTX Position: Q2 2023 in Review

TT International Asset Management sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 8,000 shares — an estimated $996K sold.

TT International Asset Management first reported a position in BNTX in Q4 2020 and held it in 7 quarters. The position peaked at $1.8M in Q4 2022. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

TT International Asset Management reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
TT International Asset Management sold 8,000 BioNTech shares in Q2 2023, an estimated $996K.
TT International Asset Management first reported a position in BioNTech in Q4 2020 and held it in 7 quarters.
TT International Asset Management's BioNTech position peaked at $1.8M in Q4 2022.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on TT International Asset Management's 13F filing for Q2 2023, filed 1 Aug 2023.